Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Regular update of the Norwegian Laboratory Code System released

On January 23, 2023, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system (Norsk laboratoriekodeverk 7280.66) and associated tariffs (Laboratoriekodeverk som gir rett til refusjon) for state and private laboratories to be implemented no later than March 1, 2023.

NLK system is used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) for laboratory tests performed in outpatient settings.

Twenty-four new codes were added to NLK in the areas of medical biochemistry, immunology and transfusiology, and medical microbiology. Some examples of the newly added codes are:

  • NOR35275 P-Renin activity;
  • NPU61040 ctDNA(P)-BRAF gene;
  • NPU61013 Us-Monkeypox virus typing;
  • NPU61026 Us-Serratia marcescens DNA.

See more information in Norwegian here (codes) and here (tariffs).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.